Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
Launched by UNIVERSITY OF MICHIGAN · Apr 19, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Michigan Youth Violence Prevention Center is conducting a study to help reduce violence among teenagers. This trial is testing a program called SafERteens, which aims to provide support and resources to young people at risk of violence. The researchers want to see if adding specific strategies can help healthcare workers—like nurses and social workers—better engage with and support the teens during the program.
To participate in this study, you would need to be employed at one of the healthcare sites involved and be involved in either screening for violence or delivering the SafERteens program. Participants can expect to be part of a team effort to improve youth safety and well-being. This study is currently looking for volunteers and is open to individuals of all genders. If you're considering joining, know that your involvement could make a real difference in helping to prevent violence in adolescents.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Employed at study site
- • Participate in screening and/or SafERteens delivery.
- Exclusion Criteria:
- • Would not be expected to complete screening and/or intervention delivery
- • Would not begin screening and/or delivering SafERteens within the first 9 months of cohort implementation
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Fruitport, Michigan, United States
Grand Rapids, Michigan, United States
Muskegon, Michigan, United States
Muskegon, Michigan, United States
Muskegon, Michigan, United States
Muskegon, Michigan, United States
Muskegon, Michigan, United States
Patients applied
Trial Officials
Patrick Carter, MD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported